Journal Menu
Submit Manuscript via ScholarOne

Annals of Medicine and Medical Education
Volume 2, Issue 2 (June 2015), pp. 48-50

DOI: 10.12973/ejms.2015.141p

Downloaded 541 times.

Research Article

Published online on Jun 01, 2015

How to reference this article?


25 hydroxy vitamin D3 levels in type 2 diabetic patients

Fatih Şahpaz


Background: It has been demonstrated that vitamin D deficiency is associated with hypertension, and type 2 diabetes mellitus (T2DM). We investigate the association of 25-hydroxyvitamin D3 levels with type 2 diabetic patients. A total of 120 T2DM patients, aged between 45 and 83 years, were recruited from the outpatient clinic at DPU Evliya çelebi Education and Research Hospital from Marc 2014 to June 2014. Ninety healthy age-matched individuals constituted the control group.  Body mass index (BMI) was calculated as the weight in kilograms divided by the square of the height in meters (kg/m2).  All patients were free of diseases or medications that might interfere with their vitamin D status. This study included 120 patients with T2DM,68 females (56%) and 52 males (43%).In T2DM patients BMI(28.9±3.9), HbA1c(8.3±1.9) were significantly higher (p=<0.01) and 25(OH)D levels(9.8±8.4) were significantly lower than in controls (p=<0.01). When we made correlation analysis in diabetic patients, we found that 25OHD negatively correlated with BMI (p=<0.001, r=-0.23), HbA1c (p=<0.05, r=-0.21).  We found that vitamin D levels were significantly low in type 2 diabetics compared to non-diabetics. There was an inverse relationship between vitamin D levels and insulin resistance.Our non-diabetic population also had low 25(OH)D levels,we recommend vitamin D supplementation in our population.

Key Words: type 2 diabetes mellitus, vitamin D deficiency, Body mass index.

  1. Bhandari SK, Pashayan S, Liu IL et al. 25-hydroxyvitamin D levels and hypertension rates.    J Clin Hypertens (Greenwich) 2011;13:170-7.
  2. Wuerner G, Burnier M, Waeber B. Hypertension and vitamin D: not again. Rev Med Suisse 2011;7:121-4.
  3. EURODIAB Substudy 2 study group. Vitamin D supplement in early childhood and risk for type 1 (insulin dependent) diabetes mellitus. Diabetologia 1999;42:51-4.
  4. Thorand B, Zierer A, Huth C, et al. Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study. Diabetes Care 2011;34:2320-2.
  5.      5. Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008;88:582-6.
  6.      6. Chiu KC, Chu A, Go VI, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79;820-5.
  7. Holick MF. Vitamin D deficiency. N Eng J Med 2007;357:266-81.
  8. Clark SA, Stumpf WE, Sar M. Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes 1981;30:382-6.
  9. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 1994;267:356-60.
  10. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1, 25 dihydroxy vitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000;47:383-91.
  11. Binkley N, Novotny R, Kruger D et al. Low vitamin D status despite abundant sun exposure. JCEM 2007;92:2130-5.